Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2023-01-11 00:00:00 ET · period of report 2023-01-10 · accession 0001209191-23-003079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-11 | 2023-01-10 | ARWR | Vakiener Victoria | Dir | A - Grant | $0.00 | +7,867 | 23.3K | +51% | $0 |
| D | 2023-01-11 | 2023-01-10 | ARWR | Vakiener Victoria | Dir | D - Sale to Iss | $0.00 | -1,764 | 15.4K | -10% | $0 |
| D | 2023-01-11 | 2023-01-10 | ARWR | Vakiener Victoria | Dir | A - Grant | $0.00 | +4,593 | 4,593 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-10 | A | A | 7,867 | $0.00 | 23,284 | D | — | — | (F2) Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date. (F3) Includes a total of 15,417 shares underlying restricted stock units, which vest over three years. |
| 2 | Common | Common Stock | 2023-01-10 | D | D | 1,764 | $0.00 | 15,417 | D | — | — | (F1) Correction to previously granted award from 17,181 to 15,417. |
| 3 | Derivative | Common Stock | 2023-01-10 | A | A | 4,593 | $0.00 | 4,593 | D | $33.03 · 2024-01-10 to 2033-01-10 | 4,593 Common Stock | (F4) Represents options, which will vest in one installment on the first anniversary of the grant date. |